DHFR and cancer: Relevant drugs targeting cancer metabolism are available, with most metabolic targets focused on cancer anabolism, such as the standard methotrexate (dihydrofolate reductase inhibitor) and 5‐fluorouracil (thymidylate synthase inhibitor).144